Physician profile
Edwin L Linder
NPI 1679652408
$7,544.98
in general payments reported to CMS, 2019-2025
42 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2020: $897 · 2021: $1,631 · 2022: $811 · 2023: $1,063 · 2024: $1,145 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,542.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $900.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $790.95 | 2019-2025 | Farxiga, Airsupra |
| Abbvie INC. | $680.07 | 2021-2025 | |
| Lilly USA, LLC | $667.96 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $537.54 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $462.23 | 2019-2023 | Jardiance |
| Glaxosmithkline, LLC. | $393.78 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $353.67 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $298.83 | 2019-2021 | |
| Abbott Laboratories | $291.36 | 2021-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $281.57 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $261.12 | 2023-2025 | Rexulti |
| Alpha Cognition USA, INC. | $202.42 | 2025 | Zunveyl |
| Amarin Pharma, INC. | $159.38 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $156.19 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Linder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.